Treace Medical Concepts Inc (TMCI)
7.61
-0.02
(-0.26%)
USD |
NASDAQ |
Nov 15, 16:00
7.61
0.00 (0.00%)
After-Hours: 20:00
Treace Medical Concepts Research and Development Expense (TTM): 19.53M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 19.53M |
| June 30, 2024 | 18.92M |
| March 31, 2024 | 17.29M |
| December 31, 2023 | 15.44M |
| September 30, 2023 | 15.04M |
| June 30, 2023 | 14.49M |
| March 31, 2023 | 13.94M |
| December 31, 2022 | 13.58M |
| Date | Value |
|---|---|
| September 30, 2022 | 13.21M |
| June 30, 2022 | 11.95M |
| March 31, 2022 | 11.39M |
| December 31, 2021 | 10.20M |
| September 30, 2021 | 8.749M |
| June 30, 2021 | 7.723M |
| March 31, 2021 | 6.283M |
| December 31, 2020 | 5.848M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
5.848M
Minimum
Dec 2020
19.53M
Maximum
Sep 2024
12.72M
Average
13.40M
Median
Research and Development Expense (TTM) Benchmarks
| Stryker Corp | 1.458B |
| Perspective Therapeutics Inc | 28.53M |
| Retractable Technologies Inc | 0.654M |
| Xtant Medical Holdings Inc | 2.145M |
| Catheter Precision Inc | 0.219M |